These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statin trials and goals of cholesterol-lowering therapy after AMI. Pedersen TR Am Heart J; 1999 Aug; 138(2 Pt 2):S177-82. PubMed ID: 10426879 [TBL] [Abstract][Full Text] [Related]
4. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention]. Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895 [No Abstract] [Full Text] [Related]
5. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260 [TBL] [Abstract][Full Text] [Related]
6. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels? Maron DJ Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):18-9. PubMed ID: 16265253 [No Abstract] [Full Text] [Related]
7. The effect of pravastatin on coronary events after myocardial infarction. Hazzard WR; Ettinger WH N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700 [No Abstract] [Full Text] [Related]
13. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study]. März W MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol reduction and coronary prevention. Prabhakaran D Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704 [No Abstract] [Full Text] [Related]
15. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262 [TBL] [Abstract][Full Text] [Related]
16. Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine. Lee TM; Su SF; Chou TF; Tsai CH Am J Cardiol; 2001 Nov; 88(10):1108-13. PubMed ID: 11703953 [TBL] [Abstract][Full Text] [Related]
17. Lowering cholesterol with drugs and diet. Pedersen TR N Engl J Med; 1995 Nov; 333(20):1350-1. PubMed ID: 7566029 [No Abstract] [Full Text] [Related]
18. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401 [TBL] [Abstract][Full Text] [Related]
20. Statins for stroke: the second story? Plutzky J; Ridker PM Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683 [No Abstract] [Full Text] [Related] [Next] [New Search]